Last reviewed · How we verify
Pain Relieving
A pain relief product that works through unspecified mechanisms to reduce pain symptoms.
A pain relief product that works through unspecified mechanisms to reduce pain symptoms. Used for Pain relief (unspecified type).
At a glance
| Generic name | Pain Relieving |
|---|---|
| Also known as | Standard Post-operative pain medications other than intrathecal morphine, Neosporin® Plus Pain Relieving Cream formula with pH balance technology |
| Sponsor | Sonoran Spine Research and Education Foundation |
| Modality | Small molecule |
| Therapeutic area | Pain Management |
| Phase | FDA-approved |
Mechanism of action
Without specific information about the active ingredient or formulation, the exact mechanism cannot be determined. This appears to be a marketed pain relief product, but the specific molecular target and pharmacological action are not provided.
Approved indications
- Pain relief (unspecified type)
Common side effects
Key clinical trials
- Effect of Scalp Block on Intraoperative Hemodynamics and Postoperative Pain in Craniotomy Patients" (NA)
- Examining Analgesic Synergy and Efficacy in Trauma Care (PHASE4)
- Induction of Labor by Cervical Ripening and Transcutaneous Electrical Nerve Stimulation (TENS) (NA)
- Enhancing Pain Management Among Patients Diagnosed With Stage III and Stage IV of Breast Cancer: The Power of Immersive and Non-Immersive Virtual Reality-Driven Interactive Guided Imagery (NA)
- Pragmatic Comparative Effectiveness Trial of Evidence-based, On-demand, Digital Behavioral Treatments for Chronic Pain (NA)
- EFFECTS OF A FULL SPECTRUM CANNABIS EXTRACT WITH DIFFERENT DOSES OF CBD AND THC ON THE MODULATION OF FIBROMYALGIA: A PILOT, MULTICENTER, OPEN LABEL CLINICAL TRIAL (FRIDINHA) (PHASE1, PHASE2)
- Effect of Alcohol Sclerotherapy on Pelvic Pain and Quality of Life in Women With Ovarian Endometriosis (NA)
- Serratus Plane Block (SPB) Versus Capsaïcine Versus Botox-A for Chronic Neuropathic Pain in Post-mastectomy Syndrome (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Pain Relieving CI brief — competitive landscape report
- Pain Relieving updates RSS · CI watch RSS
- Sonoran Spine Research and Education Foundation portfolio CI